Related Experiment Videos
[Basal cell epithelioma of the eyelids]
T Bonvallot1, Y Raulo, J Zeller
1Service de Chirurgie Plastique et Réparatrice, Hôpital Henri-Mondor, Créteil.
Annales De Dermatologie Et De Venereologie
|January 1, 1988
Summary
Surgery offers excellent oncological outcomes for basal cell carcinoma of the eyelid, with a 94% cure rate and satisfactory cosmetic results in 85% of cases. This study compares surgical efficacy against other treatments.
Area of Science:
- Ophthalmology
- Dermatology
- Surgical Oncology
Context:
- Basal cell carcinoma (BCC) is the most common malignancy of the eyelid.
- Treatment options for eyelid BCC include surgery, radiotherapy, cryotherapy, and chemotherapy.
- Surgical management aims for complete tumor removal while preserving function and cosmesis.
Purpose:
- To evaluate the oncological, functional, and cosmetic outcomes of surgical treatment for eyelid basal cell carcinoma.
- To compare the efficacy of surgical intervention with alternative therapeutic modalities for eyelid BCC.
Summary:
- A series of 36 patients with histologically confirmed eyelid BCC underwent surgical treatment.
- The study reports a 6% recurrence rate, a 94% overall cure rate, and 85% satisfactory cosmetic results.
- Functional outcomes included ectropion in one case and epiphora in 7.4% of patients.
Impact:
- Surgical treatment demonstrates high oncological efficacy and acceptable functional and cosmetic results for eyelid BCC.
- Findings provide a benchmark for comparing surgical outcomes with other BCC treatment methods.
- The study highlights the importance of complete tumor excision and appropriate reconstructive techniques.